Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

SZTURZ Petr ADAM Zdeněk VAŠKŮ Vladimír FEIT Josef KREJČÍ Marta POUR Luděk HÁJEK Roman MAYER Jiří

Year of publication 2013
Type Article in Periodical
Magazine / Source LEUKEMIA & LYMPHOMA
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.3109/10428194.2012.738816
Field Oncology and hematology
Keywords SCLEROMYXEDEMA; DEXAMETHASONE; ADULTORUM; BUSCHKE; THALIDOMIDE; DISORDERS; PATIENT; DISEASE
Description Scleredema is a rare scleroderma-like fi bromucinosis characterized by progressive thickening of the skin caused by excessive collagen and mucin depositions in the dermis. Various treatment regimens have been proposed, however with inconsistent outcomes. Herein we are the fi rst to report a complete dermatological and hematological remission in a patient with multiple myeloma associated scleredema after bortezomib-based chemotherapy.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.